These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 22592700

  • 1. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD005049. PubMed ID: 22592700
    [Abstract] [Full Text] [Related]

  • 2. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C, Valembois L, Bergmann JF, Belmin J.
    Cochrane Database Syst Rev; 2015 Mar 28; (3):CD005049. PubMed ID: 25820938
    [Abstract] [Full Text] [Related]

  • 3. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD005049. PubMed ID: 17943835
    [Abstract] [Full Text] [Related]

  • 4. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C.
    Cochrane Database Syst Rev; 2019 Sep 04; 9(9):CD005049. PubMed ID: 31483500
    [Abstract] [Full Text] [Related]

  • 5. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.
    Lafuente-Lafuente C, Mouly S, Longás-Tejero MA, Mahé I, Bergmann JF.
    Arch Intern Med; 2006 Apr 10; 166(7):719-28. PubMed ID: 16606807
    [Abstract] [Full Text] [Related]

  • 6. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.
    Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638
    [Abstract] [Full Text] [Related]

  • 7. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K, Ahmad M, Carrington M, Ioannou A, Taylor J, Razvi Y, Papageorgiou N, Mead GE, Nevis IF, D'Ascenzo F, Wilton SB, Lambiase PD, Morillo CA, Kwong JS, Providencia R.
    Cochrane Database Syst Rev; 2024 Jun 03; 6(6):CD013255. PubMed ID: 38828867
    [Abstract] [Full Text] [Related]

  • 8. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 03; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 9. Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.
    Bray JJH, Warraich M, Whitfield MG, Peter CU, Baral R, Ahmad M, Ahmad S, Abraham GR, Kirresh A, Sahibzada MS, Muzaffar A, Tomson J, Lambiase PD, Captur G, Banerjee A, Providencia R.
    Cochrane Database Syst Rev; 2023 Mar 13; 3(3):CD013765. PubMed ID: 36915032
    [Abstract] [Full Text] [Related]

  • 10. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.
    Health Technol Assess; 2010 Oct 13; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A, Husser D, Cannom DS.
    Am J Cardiovasc Drugs; 2005 Oct 13; 5(6):371-8. PubMed ID: 16259525
    [Abstract] [Full Text] [Related]

  • 12. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
    Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM.
    Card Electrophysiol Rev; 2003 Sep 13; 7(3):201-7. PubMed ID: 14739713
    [Abstract] [Full Text] [Related]

  • 13. [Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
    Koenig A, Theolade R, Chauvin M, Brechenmacher C.
    Presse Med; 1993 Nov 20; 22(36):1827-32. PubMed ID: 8309912
    [Abstract] [Full Text] [Related]

  • 14. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN, Tang XC, Reda D, Singh BN.
    Heart Rhythm; 2009 Feb 20; 6(2):152-5. PubMed ID: 19187902
    [Abstract] [Full Text] [Related]

  • 15. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN, Mody FV, Lopez B, Sarma JS.
    Am J Cardiol; 1999 Nov 04; 84(9A):161R-173R. PubMed ID: 10568677
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC, Dorland R, Allessie MA.
    J Cardiovasc Electrophysiol; 1999 Feb 04; 10(2):178-93. PubMed ID: 10090222
    [Abstract] [Full Text] [Related]

  • 17. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
    Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A.
    Heart; 2002 May 04; 87(5):443-8. PubMed ID: 11997417
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.
    Miller MR, McNamara RL, Segal JB, Kim N, Robinson KA, Goodman SN, Powe NR, Bass EB.
    J Fam Pract; 2000 Nov 04; 49(11):1033-46. PubMed ID: 11093570
    [Abstract] [Full Text] [Related]

  • 19. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.
    Deneer VH, Borgh MB, Kingma JH, Lie-A-Huen L, Brouwers JR.
    Pharm World Sci; 2004 Apr 04; 26(2):66-78. PubMed ID: 15085940
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D, Opolski G, Torbicki A.
    Med Sci Monit; 2001 Apr 04; 7(1):68-73. PubMed ID: 11208496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.